{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:42:44Z","timestamp":1768441364450,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jgaronline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jgar.2015.09.002","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T11:16:23Z","timestamp":1445598983000},"page":"237-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Reviewing the importance and evolution of fungal infections and potential antifungal resistance in haematological patients"],"prefix":"10.1016","volume":"3","author":[{"given":"Alessandro","family":"Busca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Tortorano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livio","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2015.09.002_bib0305","first-page":"986","article-title":"Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989\u20132003)","volume":"91","author":"Chamilos","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.jgar.2015.09.002_bib0310","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3324\/haematol.2009.012054","article-title":"Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study","volume":"95","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.jgar.2015.09.002_bib0315","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/1469-0691.12014","article-title":"Hema e-Chart Group, Italy. Hema e-Chart registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections","volume":"19","author":"Nosari","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2015.09.002_bib0320","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/517849","article-title":"Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality\u2014SEIFEM-C report","volume":"44","author":"Pagano","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2015.09.002_bib0325","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jinf.2010.06.018","article-title":"Trends in the postmortem epidemiology of invasive fungal infections at a university hospital","volume":"61","author":"Lehrnbecher","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.jgar.2015.09.002_bib0330","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/522189","article-title":"Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 Study\u2014Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne","volume":"45","author":"Pagano","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2015.09.002_bib0335","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/cncr.24022","article-title":"Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients","volume":"115","author":"Maertens","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jgar.2015.09.002_bib0340","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/bmt.2010.177","article-title":"Reduction of infection-related mortality after allogeneic PBSCT from HLA-identical siblings: longitudinal analysis from 1994 to 2008 at a single institution","volume":"46","author":"Martino","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jgar.2015.09.002_bib0345","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bbmt.2014.03.004","article-title":"Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)","volume":"20","author":"Girmenia","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jgar.2015.09.002_bib0350","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/jac\/dkp355","article-title":"Infectious Disease Group of the EORTC. An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients","volume":"64","author":"Viscoli","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2015.09.002_bib0355","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/bmt.2009.334","article-title":"Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study","volume":"45","author":"Herbrecht","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jgar.2015.09.002_bib0360","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2015.09.002_bib0365","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.blre.2009.11.003","article-title":"Current therapeutic approaches to fungal infections in immunocompromised hematological patients","volume":"24","author":"Pagano","year":"2010","journal-title":"Blood Rev"},{"key":"10.1016\/j.jgar.2015.09.002_bib0370","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Blood and Marrow Transplant Clinical Trials Network. Randomized double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jgar.2015.09.002_bib0375","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2141.2011.08838.x","article-title":"IMPROVIT Study Group. Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation","volume":"155","author":"Marks","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jgar.2015.09.002_bib0380","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2015.09.002_bib0385","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation\u2014a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2015.09.002_bib0390","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1086\/514731","article-title":"Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)","volume":"28","author":"Viscoli","year":"1999","journal-title":"Clin lnfect Dis"},{"key":"10.1016\/j.jgar.2015.09.002_bib0395","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijantimicag.2006.01.002","article-title":"Candidaemia in Europe: epidemiology and resistance","volume":"27","author":"Tortorano","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2015.09.002_bib0400","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s15010-013-0455-6","article-title":"A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade","volume":"41","author":"Tortorano","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.jgar.2015.09.002_bib0405","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1086\/502104","article-title":"Breakthrough candidemia in patients with cancer differs from de novo candidemia in host factors and Candida species but not intensity","volume":"23","author":"Kontoyiannis","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2015.09.002_bib0410","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1128\/JCM.02474-10","article-title":"Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006","volume":"49","author":"Lockhart","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2015.09.002_bib0415","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10096-002-0699-z","article-title":"Invasive aspergillosis in 2002: an update","volume":"21","author":"Kontoyiannis","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2015.09.002_bib0420","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/339202","article-title":"Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients","volume":"34","author":"Marr","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2015.09.002_bib0425","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2015.09.002_bib0430","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in the era of Aspergillus-active antifungal therapy in a tertiary care cancer center: a case\u2013control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jgar.2015.09.002_bib0435","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJM200402263500923","article-title":"Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants","volume":"350","author":"Marty","year":"2004","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.jgar.2015.09.002_bib0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12569","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Fungal Infection Study Group (EFISG), and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management or rare and emerging fungal disease","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2015.09.002_bib0445","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1179\/joc.2009.21.3.272","article-title":"In vitro antifungal activity of isavuconazole against 345 Mucorales isolates collected at study centers in eight countries","volume":"21","author":"Verveij","year":"2009","journal-title":"J Chemother"},{"key":"10.1016\/j.jgar.2015.09.002_bib0450","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/civ571","article-title":"Isavuconazole: a new broad-spectrum triazole antifungal agent","author":"Miceli","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.jgar.2015.09.002_bib0455","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1469-0691.12465","volume":"20","author":"Tortorano","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2015.09.002_bib0460","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s10096-013-1924-7","article-title":"Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment","volume":"32","author":"Guarro","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2015.09.002_bib0465","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1086\/421950","article-title":"Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases","volume":"39","author":"Steinbach","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2015.09.002_bib0470","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.diagmicrobio.2005.01.001","article-title":"Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli","volume":"52","author":"Lionakis","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2015.09.002_bib0475","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2141.2005.05763.x","article-title":"Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience","volume":"131","author":"Lass-Fl\u00f6rl","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jgar.2015.09.002_bib0480","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1179\/joc.2008.20.6.756","article-title":"In vitro activity of amphotericin B against Aspergillus terreus isolates from different countries and regions","volume":"20","author":"Tortorano","year":"2008","journal-title":"J Chemother"},{"key":"10.1016\/j.jgar.2015.09.002_bib0485","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1093\/jac\/dku241","article-title":"Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy","volume":"69","author":"Hachem","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2015.09.002_bib0490","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1099\/jmm.0.044867-0","article-title":"Invasive aspergillosis caused by cryptic Aspergillus species: a report of two consecutive episodes in a patient with leukaemia","volume":"62","author":"Pel\u00e1ez","year":"2013","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2015.09.002_bib0495","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/00365549709011864","article-title":"In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B: acquired resistance to itraconazole","volume":"29","author":"Chryssanthou","year":"1997","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jgar.2015.09.002_bib0500","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/AAC.41.6.1364","article-title":"Itraconazole resistance in Aspergillus fumigatus","volume":"41","author":"Denning","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2015.09.002_bib0505","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drup.2009.09.002","article-title":"Azole resistance in Aspergillus: proposed nomenclature and breakpoints","volume":"12","author":"Verweij","year":"2009","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.jgar.2015.09.002_bib0510","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/JCM.02136-10","article-title":"Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Aspergillus species to the triazoles","volume":"49","author":"Pfaller","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2015.09.002_bib0515","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/jac\/dkq279","article-title":"Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009","volume":"65","author":"Bueid","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2015.09.002_bib0520","series-title":"23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)","first-page":"989","article-title":"Azole antifungal resistance in Aspergillus fumigatus complex: 2010 and 2011","author":"Moore","year":"2013"},{"key":"10.1016\/j.jgar.2015.09.002_bib0525","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.jgar.2015.09.002_bib0530","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007\u20132009","volume":"17","author":"Van der Linden","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2015.09.002_bib0535","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1128\/JCM.40.7.2648-2650.2002","article-title":"Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998","volume":"40","author":"Verveij","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2015.09.002_bib0540","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jac\/dkq041","article-title":"Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in The Netherlands","volume":"65","author":"Klaassen","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2015.09.002_bib0545","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1128\/AAC.02487-12","article-title":"Is azole resistance in Aspergillus fumigatus a problem in Spain?","volume":"57","author":"Escribano","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2015.09.002_bib0550","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2015.09.002_bib0555","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1128\/AAC.45.11.2987-2990.2001","article-title":"Critical annotations to the use of azole antifungals for plant protection","volume":"45","author":"Hof","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2015.09.002_bib0560","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/cid\/cit320","article-title":"Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles","volume":"57","author":"Van der Linden","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2015.09.002_bib0565","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry","volume":"45","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2015.09.002_bib0570","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","article-title":"French Mycosis Study Group. Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005\u20132007)","volume":"17","author":"Lortholary","year":"2011","journal-title":"Clin Microbol Infect"},{"key":"10.1016\/j.jgar.2015.09.002_bib0575","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey","volume":"43","author":"Cornillet","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2015.09.002_bib0580","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/JCM.00854-09","article-title":"Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network","volume":"47","author":"Baddley","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2015.09.002_bib0585","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jac\/dkq450","article-title":"Low prevalence of resistance to azole in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies","volume":"66","author":"Alanio","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2015.09.002_bib0590","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/ejh.12426","article-title":"Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study","volume":"94","author":"Nachbaur","year":"2015","journal-title":"Eur J Hematol"},{"key":"10.1016\/j.jgar.2015.09.002_bib0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0103113","article-title":"Incidence of Cyp51 A key mutations in Aspergillus fumigatus\u2014a study on primary clinical samples of immunocompromised patients in the period of 1995\u20132013","volume":"9","author":"Spiess","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jgar.2015.09.002_bib0600","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jac\/dku566","article-title":"Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany","volume":"5","author":"Steinmann","year":"2015","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716515000946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716515000946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T21:11:00Z","timestamp":1567285860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716515000946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S2213716515000946"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2015.09.002","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reviewing the importance and evolution of fungal infections and potential antifungal resistance in haematological patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2015.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}